News from the life sciences community north of Boston
September 2022
Yesterday, the federal government pledged $2 billion in funding efforts to build or expand drug manufacturing sites in the U.S. and ready the raw materials needed to respond to a new pandemic. Read more in STAT News.
The announcement is related to an Executive Order signed by President Biden in Boston this week to create a National Biotechnology and Biomanufacturing Initiative. The effort is intended to increase the capacity of domestic biomanufacturing, seek out new markets for bio-based products, turbocharge research and development efforts, train new workers, and enhance privacy standards for human biological data.
AP Photo/Evan Vucci
Join Us for a MassBio Mixer on September 22!
Cummings Properties is pleased to sponsor the next MassBio Regional Mixer, Thursday, September 22 at 5 PM at Old Planters Brewing in Beverly. Connect with your colleagues and network with other life sciences professionals from MetroNorth. Appetizers and drinks will be served. Register.

The event is free for MassBio members. If you are a Cummings client, but not a MassBio member, and would like to attend, please contact client engagement manager Sue Howland to join as our guest. We hope to see you there!
BioEcho Life Sciences GmbH, an international biotechnology firm, has opened its first office in the United States at TradeCenter 128 in Woburn. The Germany-based company is leasing 3,800 square feet of office and laboratory space.
BioEcho develops and manufactures kits for DNA and RNA extraction. Its products are used in COVID testing, plant and animal breeding and research, and biopharmaceutical research and development.

Markus Müller, Ph.D., is founder and managing director.
Congratulations to Laszlo Varady, president of Rilas Technologies, Inc., on the company's recent expansion and move to 400 West Cummings Park in Woburn. In addition to providing purification and analytical solutions for the biotech community, Rilas now offers incubator space to biotech companies looking to get their research and development underway as quickly and efficiently as possible. The new Rilas offering combines the traditional incubator model with the unique analytical and purification capabilities that Rilas has perfected over the decades, resulting in an optimized workflow and enabling biotechs to achieve results faster.
Congratulations to Biocytogen Pharmaceuticals Co., Ltd. of Beijing, which recently announced its debut on the Main Board of the Stock Exchange of Hong Kong with a $60 million IPO.

Biocytogen has established a series of genetically modified animal and cell models using advanced proprietary technologies, including target humanized mice and severely immunodeficient mice. The company harnesses these specialized models to provide preclinical pharmacology evaluation services for global pharmaceutical/biotech companies to accelerate the research and development of novel drugs.

Biocytogen Boston Corporation (50 Audubon Road, Wakefield), provides antibody discovery services and preclinical pharmacology services to clients in the United States and abroad.
Azurity Pharmaceuticals, Inc. (8 Cabot Road, Woburn), a pharmaceutical company focused on developing innovative dose-forms and formulations of products to serve the needs of overlooked patients, recently announced that the U.S. Food and Drug Administration (FDA) has approved Konvomep™ (omeprazole and sodium bicarbonate for oral suspension). Konvomep™ is approved for the treatment of active benign gastric ulcer and reduction of risk of upper gastrointestinal bleeding in critically ill patients.
Asymchem (10 Gill Street, Woburn) is partnering with BioXchange during Boston Biotech Week to host an outdoor event at the spacious Lookout Rooftop Bar located atop the Envoy Hotel in Boston's Seaport District. Come network with industry colleagues while enjoying local flavors, craft cocktails, and microbrews – all with a stunning view of Boston Harbor. Tuesday, September 27, 6 PM - 9 PM. Register.
Commercialization Strategies for Biotech: The many pathways for realizing clinical success
It is becoming more critical today for life sciencescompanies to stretch their dollars into pre-clinical research and, ultimately, commercial viability. Join North Shore Technology Council's BioSciences Forum for a panel discussion that will review some of the many strategies and options biotech companies have at their disposal and the effects these decisions may have on their ability to pivot and address new challenges with their research and platforms. Speakers include Ravi Samavedam, chief innovation officer of Azzure Group, and Leslie Lippard, senior director, strategy & portfolio analytics, Alnylam Pharmaceuticals. Thursday, September 29, 5 PM - 7 PM. Register.
Coming September 27-30 as a hybrid event series, Biotech Week Boston will convene the most innovative scientific minds and business leaders in Boston and around the world for a unique experience spanning the drug development value chain.
12 Gill Street, Woburn
6,600 SF BSL2 Facility Available November 2022
This 6,569 SF lab and office suite is located in a vibrant life sciences cluster just off I-93 at the I-95 interchange. Contact a Cummings lab specialist at or 781-983-7039 for details. Features include:
  • First-class building
  • Corner unit with abundant light
  • Convenient location at I-93/I-95
  • Close to Woburn Village lifestyle center
Chris Barkey (left), CEO and senior director at Barkey (500 West Cummings Park, Woburn), and colleagues recently convened experts to discuss the acceleration of breakthrough therapies in cell and gene therapy to cure cancer, and to meet Emily Whitehead (right) as patient zero of Car-T cell therapy. The program featured Tom Whitehead (center), Bruce Levine, and Stephan Grupp, who discussed their visions in cell and gene research.
On Monday, the Biden administration appointed Ginkgo Bioworks executive Renee Wegrzyn as the first director of the Advanced Research Projects Agency for Health, a new federal agency focused on biomedical and health research and innovation. Wegrzyn joined President Biden at the John F. Kennedy Presidential Library and Museum, where he discussed the goal of cutting the cancer death rate in half over the next 25 years. Read more in The Boston Globe.
Have news to share? Please let us know! We are interested in company news, personnel changes, product launches, funding updates, events, and more. Contact Sue Howland, client engagement manager, at to share your news for upcoming newsletters. We look forward to hearing from you.
Keep up with news from the Cummings community by following us on LinkedInFacebookTwitter, and Instagram.